Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AbfiledCriticalAstra Ab
Priority to UY27100ApriorityCriticalpatent/UY27100A1/en
Publication of UY27100A1publicationCriticalpatent/UY27100A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a una forma sustancialmente cristalina de EtO2-C-CH2-(R)CgL-Aze-Pab-OH o a una sal farmacéuticamente aceptable de la misma, a composiciones farmacéuticas que las contienen y a procesos para obtener las mismas.The present invention relates to a substantially crystalline form of EtO2-C-CH2- (R) CgL-Aze-Pab-OH or a pharmaceutically acceptable salt thereof, pharmaceutical compositions containing them and processes for obtaining them.
UY27100A2001-12-272001-12-27
CRYSTAL FORMS OF ETO2C-CH2- (R) CGL-AZE-PAB-OH
UY27100A1
(en)
CRYSTAL FORMS OF ETO2C-CH2- (R) CGL-AZE-PAB-OH, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL FORMULATION, AND USE OF THESE COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT.
Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5-5-dioxo-6-methyl-dibenzo [c, f] [1,2] thiazepine and application for the synthesis of detianeptine